AI
AXS Investments LLC
13F filer · CIK 0001801467Reported Aug 10, 2026
Net buyer this quarter
13F portfolio value$353MU.S. long equity reported on 13F
Positions17311 new · 11 closed
Net flow last quarter+$68.8MBuys minus sells
Top 10 positions weight62.7%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 10, 2026173 positions | |||||
| $171M | 48.57% | Not reported | +87.3% | Q1 2021 | |
| $10.9M | 3.09% | 0.00% | -3.3% | Q1 2021 | |
| $5.76M | 1.63% | Not reported | -19.2% | Q1 2021 | |
| $5.15M | 1.46% | 0.00% | -10.0% | Q1 2021 | |
| $5.1M | 1.45% | 0.00% | -1.4% | Q1 2021 | |
| $4.93M | 1.40% | 0.00% | +5.5% | Q2 2021 | |
| $4.76M | 1.35% | Not reported | +4.9% | Q1 2021 | |
| $4.75M | 1.35% | 0.00% | +28.7% | Q1 2021 | |
| $4.19M | 1.19% | 0.00% | Not reported | Q3 2023 | |
| $4.16M | 1.18% | 0.00% | +136.1% | Q1 2021 | |
| $3.74M | 1.06% | 0.00% | -23.1% | Q1 2021 | |
| $3.72M | 1.05% | 0.00% | +9.7% | Q1 2021 | |
| $3.6M | 1.02% | 0.00% | -6.8% | Q1 2021 | |
| $3.39M | 0.96% | 0.00% | +43.9% | Q1 2021 | |
| $3.32M | 0.94% | 0.00% | -16.0% | Q1 2021 | |
| $3.26M | 0.92% | 0.00% | +2.3% | Q1 2021 | |
| $3.11M | 0.88% | 0.00% | -3.5% | Q1 2021 | |
| $2.88M | 0.82% | 0.00% | +11.7% | Q1 2021 | |
| $2.6M | 0.74% | 0.00% | +0.5% | Q1 2021 | |
| $2.55M | 0.72% | 0.00% | -7.5% | Q4 2024 | |
| $2.32M | 0.66% | 0.00% | -28.9% | Q1 2021 | |
| $2.11M | 0.60% | 0.00% | -2.5% | Q1 2021 | |
| $2.05M | 0.58% | 0.00% | Not reported | Q1 2023 | |
| $1.81M | 0.51% | 0.00% | -1.5% | Q1 2021 | |
| $1.76M | 0.50% | 0.00% | +3.2% | Q1 2021 | |
| $1.73M | 0.49% | 0.00% | -7.6% | Q1 2021 | |
| $1.49M | 0.42% | 0.01% | Not reported | Q2 2023 | |
| $1.46M | 0.41% | 0.00% | -19.4% | Q2 2022 | |
| $1.45M | 0.41% | 0.00% | +1.5% | Q1 2021 | |
| $1.44M | 0.41% | Not reported | -19.4% | Q1 2021 | |
| $1.33M | 0.38% | 0.00% | -3.4% | Q3 2024 | |
| $1.31M | 0.37% | 0.00% | -3.4% | Q4 2024 | |
| $1.29M | 0.37% | 0.00% | +4.7% | Q1 2021 | |
| SPPROCSofgen Pharma, S.A. | $1.26M | 0.36% | 0.02% | Not reported | Q4 2025 |
| $1.19M | 0.34% | 0.00% | Not reported | Q2 2023 | |
| $1.18M | 0.33% | 0.00% | +2.2% | Q2 2021 | |
| $1.12M | 0.32% | 0.00% | -3.3% | Q4 2021 | |
| $1.11M | 0.31% | 0.00% | -18.9% | Q1 2021 | |
| $1.09M | 0.31% | 0.00% | +27.1% | Q1 2021 | |
| $1.07M | 0.30% | 0.00% | -3.4% | Q1 2021 | |
| $1.07M | 0.30% | 0.00% | -4.1% | Q1 2021 | |
| $1.02M | 0.29% | 0.00% | -5.9% | Q1 2021 | |
| $1.01M | 0.29% | 0.00% | -2.2% | Q1 2021 | |
| $996K | 0.28% | 0.00% | -7.9% | Q4 2024 | |
| $968K | 0.27% | 0.00% | -5.1% | Q2 2025 | |
| $956K | 0.27% | 0.00% | -13.3% | Q1 2022 | |
| $954K | 0.27% | 0.01% | -3.5% | Q1 2025 | |
| $948K | 0.27% | 0.01% | Not reported | Q1 2024 | |
| $944K | 0.27% | 0.00% | +3.4% | Q1 2021 | |
| $935K | 0.27% | 0.00% | New | Q2 2026 | |
| Q1 2026Reported May 6, 2026172 positions | |||||
| $71.7M | 28.94% | Not reported | +0.8% | Q1 2021 | |
| $6.21M | 2.51% | Not reported | +3.1% | Q1 2021 | |
| $5.86M | 2.37% | 0.00% | -17.5% | Q2 2021 | |
| $4.61M | 1.86% | Not reported | -17.8% | Q1 2021 | |
| $4.6M | 1.86% | 0.00% | -16.6% | Q1 2021 | |
| $4.51M | 1.82% | 0.00% | -34.0% | Q1 2021 | |
| $4.35M | 1.75% | 0.00% | -25.2% | Q1 2021 | |
| $3.93M | 1.59% | Not reported | -3.3% | Q1 2025 | |
| $3.83M | 1.55% | 0.00% | -5.3% | Q1 2021 | |
| $3.46M | 1.40% | 0.00% | -7.2% | Q1 2021 | |
| $3.3M | 1.33% | 0.00% | -20.0% | Q1 2021 | |
| $3.3M | 1.33% | 0.00% | -3.6% | Q1 2021 | |
| $3.28M | 1.32% | 0.00% | -0.9% | Q1 2021 | |
| $3.13M | 1.26% | 0.00% | Not reported | Q3 2023 | |
| $2.75M | 1.11% | 0.00% | -12.1% | Q1 2021 | |
| $2.29M | 0.92% | 0.00% | +8.4% | Q1 2021 | |
| $2.28M | 0.92% | 0.00% | -9.7% | Q1 2021 | |
| $2.19M | 0.88% | 0.00% | -12.1% | Q1 2021 | |
| $2.13M | 0.86% | 0.00% | +18.6% | Q4 2024 | |
| $2.12M | 0.85% | 0.00% | +59.0% | Q1 2021 | |
| $1.99M | 0.80% | 0.00% | Not reported | Q1 2023 | |
| $1.89M | 0.76% | 0.00% | -1.6% | Q1 2021 | |
| $1.87M | 0.75% | 0.00% | -11.1% | Q1 2021 | |
| $1.8M | 0.73% | 0.00% | -8.6% | Q1 2021 | |
| $1.71M | 0.69% | Not reported | -12.5% | Q1 2021 | |
| SPPROCSofgen Pharma, S.A. | $1.66M | 0.67% | 0.02% | Not reported | Q4 2025 |
| $1.5M | 0.61% | 0.00% | -10.6% | Q1 2021 | |
| $1.48M | 0.60% | 0.00% | -12.1% | Q1 2021 | |
| $1.45M | 0.59% | 0.00% | -14.9% | Q1 2021 | |
| $1.45M | 0.59% | 0.00% | Not reported | Q1 2023 | |
| $1.4M | 0.57% | 0.00% | -3.3% | Q4 2024 | |
| $1.35M | 0.54% | 0.01% | Not reported | Q2 2023 | |
| $1.29M | 0.52% | 0.00% | -1.0% | Q1 2021 | |
| $1.23M | 0.50% | 0.00% | -12.9% | Q1 2021 | |
| $1.21M | 0.49% | 0.00% | -39.1% | Q1 2021 | |
| $1.2M | 0.49% | 0.00% | -10.6% | Q1 2021 | |
| $1.16M | 0.47% | 0.00% | -3.3% | Q3 2024 | |
| $1.14M | 0.46% | 0.00% | -7.8% | Q1 2021 | |
| $1.08M | 0.44% | 0.00% | -3.3% | Q1 2021 | |
| $1.06M | 0.43% | 0.00% | +1.4% | Q1 2021 | |
| $1.03M | 0.42% | 0.00% | -4.0% | Q4 2024 | |
| $1.01M | 0.41% | 0.00% | -36.5% | Q1 2021 | |
| $991K | 0.40% | 0.00% | -11.3% | Q1 2021 | |
| $915K | 0.37% | 0.00% | -12.7% | Q1 2021 | |
| $885K | 0.36% | 0.00% | Not reported | Q2 2022 | |
| $873K | 0.35% | 0.00% | -29.8% | Q1 2021 | |
| $869K | 0.35% | 0.00% | +1162.4% | Q1 2021 | |
| $827K | 0.33% | 0.00% | Not reported | Q2 2023 | |
| $801K | 0.32% | 0.00% | -6.6% | Q1 2021 | |
| $793K | 0.32% | 0.00% | -4.6% | Q1 2023 | |
| Q4 2025Reported May 13, 2026170 positions | |||||
| $75.7M | 26.07% | Not reported | -10.5% | Q1 2021 | |
| $8.64M | 2.97% | 0.00% | -6.5% | Q2 2021 | |
| $7.31M | 2.52% | 0.00% | -1.1% | Q1 2021 | |
| $6.48M | 2.23% | Not reported | +6.2% | Q1 2021 | |
| $6.31M | 2.17% | Not reported | +38.2% | Q1 2021 | |
| $6.01M | 2.07% | 0.00% | -29.8% | Q1 2021 | |
| $5.66M | 1.95% | 0.00% | +5.0% | Q1 2021 | |
| $5.29M | 1.82% | 0.00% | -1.3% | Q1 2021 | |
| $4.71M | 1.62% | 0.00% | +3.3% | Q1 2021 | |
| $4.38M | 1.51% | 0.00% | +7.0% | Q1 2021 | |
| $3.99M | 1.37% | 0.00% | -2.1% | Q1 2021 | |
| $3.91M | 1.35% | Not reported | -36.1% | Q1 2025 | |
| $3.82M | 1.32% | 0.00% | 0.0% | Q1 2021 | |
| $3.53M | 1.22% | 0.00% | -1.3% | Q1 2021 | |
| $3.05M | 1.05% | 0.00% | -0.7% | Q1 2021 | |
| $3.04M | 1.05% | 0.00% | +4.9% | Q4 2024 | |
| $2.89M | 1.00% | 0.00% | -3.5% | Q1 2021 | |
| $2.59M | 0.89% | 0.00% | -0.6% | Q1 2021 | |
| $2.46M | 0.85% | 0.00% | +0.5% | Q1 2021 | |
| $2.43M | 0.84% | 0.00% | +1.3% | Q1 2021 | |
| $2.39M | 0.82% | 0.00% | +0.4% | Q1 2021 | |
| $2.38M | 0.82% | 0.00% | -2.9% | Q1 2021 | |
| $2.36M | 0.81% | 0.00% | +12.3% | Q1 2021 | |
| $2.31M | 0.80% | 0.00% | -2.0% | Q1 2021 | |
| $2.13M | 0.73% | 0.00% | -1.9% | Q1 2021 | |
| $2.05M | 0.71% | Not reported | +57.9% | Q1 2021 | |
| $2.03M | 0.70% | 0.00% | -2.3% | Q1 2021 | |
| $2.03M | 0.70% | 0.00% | Not reported | Q3 2023 | |
| $2.01M | 0.69% | 0.00% | -0.7% | Q1 2021 | |
| $1.58M | 0.54% | 0.00% | -3.2% | Q4 2024 | |
| $1.56M | 0.54% | 0.00% | -68.7% | Q1 2021 | |
| SPPROCSofgen Pharma, S.A. | $1.51M | 0.52% | 0.02% | New | Q4 2025 |
| $1.49M | 0.51% | 0.00% | -0.4% | Q1 2021 | |
| $1.45M | 0.50% | 0.00% | +12.7% | Q1 2021 | |
| $1.37M | 0.47% | 0.00% | -0.5% | Q1 2021 | |
| $1.32M | 0.46% | 0.00% | +9.5% | Q1 2021 | |
| $1.32M | 0.45% | 0.00% | -5.2% | Q1 2021 | |
| $1.31M | 0.45% | 0.00% | Not reported | Q1 2023 | |
| $1.3M | 0.45% | 0.00% | -5.1% | Q1 2021 | |
| $1.3M | 0.45% | 0.00% | +6.3% | Q2 2025 | |
| $1.28M | 0.44% | 0.00% | -5.1% | Q1 2021 | |
| $1.23M | 0.42% | Not reported | +1.3% | Q4 2023 | |
| $1.18M | 0.41% | 0.00% | -1.2% | Q1 2021 | |
| $1.13M | 0.39% | 0.00% | +3.9% | Q2 2021 | |
| $1.12M | 0.39% | 0.00% | -3.2% | Q3 2024 | |
| $1.08M | 0.37% | 0.01% | Not reported | Q2 2023 | |
| $1.01M | 0.35% | 0.00% | -3.9% | Q4 2024 | |
| $978K | 0.34% | 0.00% | -3.2% | Q1 2021 | |
| $958K | 0.33% | 0.00% | -2.8% | Q1 2023 | |
| $873K | 0.30% | Not reported | +0.5% | Q4 2021 | |
| Q3 2025Reported May 13, 2026168 positions | |||||
| $83.6M | 26.33% | Not reported | Not reported | Q1 2021 | |
| $9.48M | 2.99% | 0.00% | +4.9% | Q2 2021 | |
| $7.39M | 2.33% | 0.00% | +1.4% | Q1 2021 | |
| $6.89M | 2.17% | 0.00% | +10.8% | Q1 2021 | |
| $6.78M | 2.14% | Not reported | -2.4% | Q1 2021 | |
| $6.64M | 2.09% | 0.00% | -9.2% | Q1 2021 | |
| $6.31M | 1.99% | Not reported | +8.5% | Q1 2025 | |
| $5.91M | 1.86% | 0.00% | -10.6% | Q1 2021 | |
| $5.74M | 1.81% | 0.00% | -25.9% | Q1 2021 | |
| $4.85M | 1.53% | 0.00% | +13.7% | Q1 2021 | |
| $4.54M | 1.43% | 0.00% | +8.5% | Q1 2021 | |
| $4.29M | 1.35% | Not reported | Not reported | Q1 2021 | |
| $3.82M | 1.20% | 0.00% | +13.3% | Q1 2021 | |
| $3.64M | 1.15% | 0.00% | +4.2% | Q1 2021 | |
| $3.2M | 1.01% | 0.00% | +4.2% | Q1 2021 | |
| $3.09M | 0.97% | 0.00% | +4.2% | Q4 2024 | |
| $3.04M | 0.96% | 0.00% | +28.8% | Q1 2021 | |
| $2.94M | 0.93% | 0.00% | +3.8% | Q1 2021 | |
| $2.85M | 0.90% | 0.00% | +4.2% | Q1 2021 | |
| $2.68M | 0.85% | 0.00% | +4.2% | Q1 2021 | |
| $2.65M | 0.83% | 0.00% | +9.0% | Q1 2021 | |
| $2.56M | 0.81% | 0.00% | +9.3% | Q1 2021 | |
| $2.53M | 0.80% | 0.00% | +2.4% | Q1 2021 | |
| $2.31M | 0.73% | 0.00% | +8.3% | Q1 2021 | |
| $2.17M | 0.68% | 0.00% | +4.2% | Q1 2021 | |
| $2.09M | 0.66% | 0.00% | +4.2% | Q1 2021 | |
| $2.07M | 0.65% | 0.00% | +2.1% | Q1 2021 | |
| $1.89M | 0.59% | 0.00% | Not reported | Q3 2023 | |
| $1.76M | 0.55% | 0.00% | -0.2% | Q1 2021 | |
| $1.57M | 0.50% | 0.00% | -3.1% | Q4 2024 | |
| $1.55M | 0.49% | 0.00% | +4.2% | Q2 2025 | |
| $1.49M | 0.47% | 0.00% | +4.3% | Q1 2021 | |
| $1.46M | 0.46% | 0.00% | +7.9% | Q1 2021 | |
| $1.46M | 0.46% | Not reported | +4.2% | Q4 2023 | |
| $1.42M | 0.45% | 0.00% | +17.7% | Q1 2021 | |
| $1.41M | 0.44% | 0.00% | +7.6% | Q1 2021 | |
| $1.34M | 0.42% | 0.00% | +4.2% | Q1 2021 | |
| $1.3M | 0.41% | Not reported | -35.2% | Q1 2021 | |
| $1.27M | 0.40% | 0.00% | +24.6% | Q1 2021 | |
| $1.26M | 0.40% | 0.00% | -3.1% | Q3 2024 | |
| $1.23M | 0.39% | 0.00% | -3.1% | Q1 2021 | |
| $1.2M | 0.38% | 0.01% | +3.1% | Q4 2024 | |
| $1.2M | 0.38% | 0.00% | Not reported | Q1 2023 | |
| $1.19M | 0.38% | 0.00% | +4.2% | Q4 2022 | |
| $1.12M | 0.35% | 0.00% | +4.2% | Q2 2021 | |
| $1.1M | 0.35% | Not reported | +4.2% | Q1 2021 | |
| $1.07M | 0.34% | 0.00% | +35.2% | Q1 2021 | |
| $1.05M | 0.33% | 0.00% | +4.2% | Q4 2021 | |
| $1.04M | 0.33% | 0.00% | +0.6% | Q1 2021 | |
| $951K | 0.30% | 0.00% | +4.2% | Q1 2021 | |
Premium opens every quarter this fund has filed